Tel Aviv – Israel’s Migal Research Institute held a press conference on Thursday to reveal that they have developed a coronavirus vaccine.
The new vaccine is a by-product Migal’s development of a vaccine against IBV (Infectious Bronchitis Virus), a disease that affected poultry, whose effectiveness has been proven in pre-clinical trials carried out at the Veterinary Institute.
However, Migal later gave the genetic adjustments to IBV vaccine to adapt it to COVID-19, the human strain of coronavirus.
Migal is currently working to achieve the safety approvals to help enable in-vivo testing and to initiate the mass production of the vaccine to counter coronavirus which has claimed over 2,666 lives.
China has reported over 80,000 cases, while Canada’s preliminary research on Iran’s condition has claimed over 18,000 cases. The virus has claimed the life Iran’s former envoy to Vatican on Thursday, while other ministers of Mullah regime are quarantined.